Precision Genome Engineering and Synthetic Biology: Designing Genomes and Pathways Organizer(s): Dana Carroll and Jef D. Boeke Date: March 17 - 22, 2013 Location: Beaver Run Resort, Breckenridge, CO, USANow that we know the sequences of many genomes, from a wide variety of organisms and even from individuals with unique characteristics, many researchers have turned to making intentional modifications of those genomes. Purposes of those modifications include: introducing mutations to evaluate gene function, production of models for human genetic disease, gene correction, radical redesign of genome structure, and the generation of novel cellular networks and pathways. With this conference, we propose to bring together scientists who are: 1) developing tools for precision genome engineering; 2) using those tools for specific purposes in a wide range of organisms, including humans; 3) creating whole synthetic genomes with prospects for wholesale reengineering; 4) engineering cells with novel pathways and properties. Exchange of cutting-edge information regarding approaches, accomplishments and ambitions will augment the capabilities of each group. The meeting will provide an outstanding forum for students, postdoctoral fellows, and senior investigators who envision careers in genome and pathway design. Scholarship Deadline: November 14 2012 Discounted Abstract Deadline: November 14 2012 Abstract Deadline: December 19 2012 Discounted Registration Deadline: January 17 2013 We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:
LS9, Inc.
Sangamo BioSciences, Inc.
$2,500 - $9,999  We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:  We gratefully acknowledge the generous grant for this conference provided by: National Science Foundation (NSF)Grant No. MCB-1265353 The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the National Science Foundation; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government. |